Cointime

Laguna Pharmaceuticals

company

About

Laguna Pharmaceuticals is a biopharmaceutical company advancing vanoxerine for the treatment of atrial fibrillation.

  • 11 - 50

Highlights

Total Funding Amount
$30M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Series B
Last Funding Money Raised
$30M
Industries
Biotechnology,Health Care,Life Science
Founded date
Jan 1, 2006
Number Of Employee
11 - 50
Operating Status
Active

ChanRx Corp. intends to develop and market small molecule pharmaceuticals to treat atrial fibrillation, a common arrhythmia that can cause heart attacks and strokes. The company was founded in 2008 and is based in Cleveland, Ohio.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$30M
Laguna Pharmaceuticals has raised a total of $30M in funding over 2 rounds. Their latest funding was raised on Feb 17, 2015 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 17, 2015 Series B $30M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
Laguna Pharmaceuticals is funded by 1 investors. Versant Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Versant Ventures — Series B
Cointime
เนื้อหา
บริษัท